Trials / Completed
CompletedNCT05837741
Leucine-enriched Formulas in Patients With Tumor-induced Sarcopenia
Standard Hypercaloric, Hyperproteic vs Leucine-enriched Oral Supplements in Patients With Cancer-induced Sarcopenia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Maimónides Biomedical Research Institute of Córdoba · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Currently there is a lack of evidence for recommending specific oral supplements (OS) for nutritional support in patients with cancer, including leucine-enriched supplements.
Detailed description
Appropriate clinical trials that compare anthropometric and biochemical changes in nutritional parameters and clinical outcomes in patients with cancer-induced sarcopenia are required
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Standard hypercaloric hyperproteic oral nutritional supplement | Patients will receive nutritional support with Standard hypercaloric hyperproteic oral nutritional supplement |
| DIETARY_SUPPLEMENT | Leucine-enriched hypercaloric hyperproteic oral nutritional supplement | Patients will receive nutritional support with Leucine-enriched hypercaloric hyperproteic oral nutritional supplement |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2021-08-01
- Completion
- 2021-11-01
- First posted
- 2023-05-01
- Last updated
- 2023-05-09
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05837741. Inclusion in this directory is not an endorsement.